News & Perspective

Apr 27, 2017

Apr 27, 2017

News Scan for Apr 27, 2017

More H5N8, H5N1
Vaccination info systems
MERS overview

Mar 28, 2017

Mar 28, 2017

News Scan for Mar 28, 2017

New NIH cuts
Yellow fever from Suriname
Measles in Europe
C diff in surgical patients
New chikungunya cases
Food safety in cookbooks

Sep 05, 2013

Sep 05, 2013

News Scan for Sep 05, 2013

Call for 24/7 disease-notification feed
Measles in the Netherlands

Apr 20, 2012

Apr 20, 2012

NIH endorses recommendation to publish H5N1 studies

(CIDRAP News) – The US National Institutes of Health (NIH) has endorsed the recommendations of its biosecurity advisory committee to publish the full versions of two studies describing lab-modified, mammalian-transmissible H5N1 flu viruses, NIH officials announced today.

Jul 26, 2007

Jul 26, 2007

People likely to alter lifestyles to cut risk in a pandemic, study finds

(CIDRAP News) – A recently published survey of Europeans and Asians showed that, when faced with an influenza pandemic, most would avoid mass transit and limit shopping to essentials, and many would avoid other public places, including restaurants, theaters, and the workplace.

May 04, 2006

May 04, 2006

US awards $1 billion for cell-based flu vaccines

(CIDRAP News) – In an effort to modernize vaccine production while preparing for an influenza pandemic, the US government today awarded five contracts totaling more than $1 billion to develop cell-based technologies for making flu vaccines.

Mar 03, 2006

Mar 03, 2006

WHO sets meeting on flu pandemic containment

(CIDRAP News) – Public health experts will meet in Geneva next week to continue developing the World Health Organization's (WHO's) draft plan for quick action to head off a potential influenza pandemic.

The WHO announced the meeting as a Hong Kong official reported another possible human case of H5N1 avian flu in China, involving a 32-year-old man who died yesterday.

Jan 20, 2006

Jan 20, 2006

Report discourages use of antivirals for seasonal flu

Jan 20, 2005 (CIDRAP News) – Researchers who analyzed numerous clinical trials concluded that the two newest antiviral drugs for influenza, oseltamivir (Tamiflu) and zanamivir (Relenza), should not routinely be used against seasonal flu—a recommendation flatly rejected by the manufacturer of oseltamivir.

Sort Results

 

Narrow results

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»